↓ Skip to main content

The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia

Overview of attention for article published in BMC Infectious Diseases, July 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

blogs
1 blog
twitter
2 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
58 Mendeley
Title
The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia
Published in
BMC Infectious Diseases, July 2013
DOI 10.1186/1471-2334-13-304
Pubmed ID
Authors

Anneli Uusküla, Andres Müürsepp, Kosuke Kawai, Mait Raag, Mikk Jürisson, Matthew Pillsbury

Abstract

This analysis assessed the epidemiological and economic impact of quadrivalent human papillomavirus (HPV4: 6/11/16/18) vaccination in Estonia.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
United States 1 2%
Netherlands 1 2%
Estonia 1 2%
Unknown 54 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 17%
Student > Master 10 17%
Student > Doctoral Student 6 10%
Student > Ph. D. Student 6 10%
Student > Postgraduate 6 10%
Other 11 19%
Unknown 9 16%
Readers by discipline Count As %
Medicine and Dentistry 20 34%
Agricultural and Biological Sciences 4 7%
Nursing and Health Professions 4 7%
Social Sciences 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Other 9 16%
Unknown 13 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 November 2013.
All research outputs
#4,001,106
of 22,713,403 outputs
Outputs from BMC Infectious Diseases
#1,272
of 7,657 outputs
Outputs of similar age
#34,453
of 194,345 outputs
Outputs of similar age from BMC Infectious Diseases
#23
of 151 outputs
Altmetric has tracked 22,713,403 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,657 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 194,345 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 151 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.